1. Home
  2. EXOD vs NUVB Comparison

EXOD vs NUVB Comparison

Compare EXOD & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXOD
  • NUVB
  • Stock Information
  • Founded
  • EXOD 2015
  • NUVB 2018
  • Country
  • EXOD United States
  • NUVB United States
  • Employees
  • EXOD N/A
  • NUVB N/A
  • Industry
  • EXOD
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXOD
  • NUVB Health Care
  • Exchange
  • EXOD NYSE
  • NUVB Nasdaq
  • Market Cap
  • EXOD 1.0B
  • NUVB 959.2M
  • IPO Year
  • EXOD N/A
  • NUVB N/A
  • Fundamental
  • Price
  • EXOD $38.51
  • NUVB $2.51
  • Analyst Decision
  • EXOD
  • NUVB Strong Buy
  • Analyst Count
  • EXOD 0
  • NUVB 6
  • Target Price
  • EXOD N/A
  • NUVB $7.00
  • AVG Volume (30 Days)
  • EXOD 25.5K
  • NUVB 3.0M
  • Earning Date
  • EXOD 03-03-2025
  • NUVB 02-27-2025
  • Dividend Yield
  • EXOD N/A
  • NUVB N/A
  • EPS Growth
  • EXOD N/A
  • NUVB N/A
  • EPS
  • EXOD 1.77
  • NUVB N/A
  • Revenue
  • EXOD $89,940,000.00
  • NUVB $2,162,000.00
  • Revenue This Year
  • EXOD $73.75
  • NUVB N/A
  • Revenue Next Year
  • EXOD $30.43
  • NUVB $369.72
  • P/E Ratio
  • EXOD $21.76
  • NUVB N/A
  • Revenue Growth
  • EXOD 83.71
  • NUVB N/A
  • 52 Week Low
  • EXOD $2.30
  • NUVB $1.44
  • 52 Week High
  • EXOD $67.00
  • NUVB $4.16
  • Technical
  • Relative Strength Index (RSI)
  • EXOD N/A
  • NUVB 42.25
  • Support Level
  • EXOD N/A
  • NUVB $2.44
  • Resistance Level
  • EXOD N/A
  • NUVB $2.77
  • Average True Range (ATR)
  • EXOD 0.00
  • NUVB 0.23
  • MACD
  • EXOD 0.00
  • NUVB -0.04
  • Stochastic Oscillator
  • EXOD 0.00
  • NUVB 6.40

About EXOD EXODUS MOVEMENT INC

Exodus Movement Inc is a self-custodial platform that connects people with the world of decentralized finance and the power of the blockchain. Available for desktop and mobile, it allows users to secure, manage and exchange cryptocurrencies like Bitcoin, Ethereum. Geographical presence in Europe, United States, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and Canada and Latin America (Other Americas).

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Share on Social Networks: